What is the current Red Blood Cell Lysis Buffer market size?

The current Red Blood Cell Lysis Buffer market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Red Blood Cell Lysis Buffer market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Red Blood Cell Lysis Buffer market?

Key drivers include rising research activities and growing applications in diagnostics and therapeutics.

What are the major challenges facing the Red Blood Cell Lysis Buffer market?

Challenges include high production costs and stringent regulatory requirements.

Which regions are leading the Red Blood Cell Lysis Buffer market?

North America and Europe are leading the market due to well-established research infrastructure.

Who are the top companies in the Red Blood Cell Lysis Buffer market?

Top companies include Thermo Fisher, Merck, and Bio-Rad, offering high-quality products.

What future opportunities exist in the Red Blood Cell Lysis Buffer market?

Future opportunities include emerging applications in personalized medicine and gene therapy.

How is technology impacting the Red Blood Cell Lysis Buffer market?

Advances in technology are improving product efficiency and reducing costs, driving market growth.

What is the current regulatory landscape for the Red Blood Cell Lysis Buffer market?

The regulatory landscape is evolving, with increasing focus on product safety and efficacy.

What is the future outlook for the Red Blood Cell Lysis Buffer market?

The future outlook is positive, with growing demand and emerging opportunities driving market expansion.

Red Blood Cell Lysis Buffer Market Growing at CAGR — 2026 Report

Red Blood Cell Lysis Buffer by Application (Research Laboratory, Hospital, Others), by Types (Red Blood Cell Lysis Buffer, Type A (Nucleic Acid Purification), Red Blood Cell Lysis Buffer, Type B (Flow Cytometric Analysis)), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Red Blood Cell Lysis Buffer Market Overview

The Red Blood Cell Lysis Buffer market refers to the industry involved in the production and distribution of reagents used to break down red blood cells, releasing their contents for further analysis. As a crucial component in various biomedical research and diagnostic applications, the Red Blood Cell Lysis Buffer market size is expected to experience significant growth, driven by increasing demand for market forecast and industry expansion. The scope of this market encompasses a range of products, including buffers, reagents, and kits, used in applications such as research, diagnostics, and biopharmaceutical production. According to recent estimates, the current Red Blood Cell Lysis Buffer market size is approximately $1.3 billion. The growth outlook for this market is promising, with a projected compound annual growth rate (CAGR) of 8.5% during the forecast period from 2026 to 2033, driven by macro drivers such as advancements in biomedical research and increasing investment in the biotechnology sector.

Loading chart…

Several key forces are shaping the Red Blood Cell Lysis Buffer industry, including technology shifts towards more efficient and cost-effective lysis methods, regulations governing the use of biological samples, and competitive intensity driven by the entry of new market players. The largest region in terms of market size is currently North America, while the fastest-growing region is expected to be the Asia-Pacific region, driven by increasing investment in biomedical research and biotechnology in countries such as China and India. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments to remain competitive and capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Norgen Biotek Corp.; PeproTech, Inc.; Absin; Beijing Solarbio Science and Technology Co., Ltd.; Beyotime Biotechnology; Sigma-Aldrich; Invent Biotechnologies, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Red Blood Cell Lysis Buffer market is poised for significant growth, driven by increasing demand for red blood cell analysis in various applications. Understanding the market dynamics is crucial for stakeholders to navigate this complex landscape and capitalize on emerging opportunities.

Growth Drivers2 items

Advances in genomics and proteomics are driving the adoption of Red Blood Cell Lysis Buffer in research and diagnostic applications, contributing to the growth forecast of the Red Blood Cell Lysis Buffer market size.

Increasing investments in biotechnology and pharmaceutical research are expected to fuel the demand for Red Blood Cell Lysis Buffer, further expanding the Red Blood Cell Lysis Buffer market.

Restraints2 items

Stringent regulations and standards for the use of Red Blood Cell Lysis Buffer in clinical settings may hinder the market growth, affecting the overall Red Blood Cell Lysis Buffer market size.

High production costs and pricing pressures may limit the adoption of Red Blood Cell Lysis Buffer in price-sensitive markets, impacting the growth forecast of the Red Blood Cell Lysis Buffer market.

Opportunities2 items

Emerging applications in personalized medicine and biomarker discovery are expected to create new opportunities for Red Blood Cell Lysis Buffer manufacturers, driving the growth of the Red Blood Cell Lysis Buffer market.

Increasing collaborations and partnerships between research institutions and industry players are likely to accelerate the development of new Red Blood Cell Lysis Buffer products, contributing to the expansion of the Red Blood Cell Lysis Buffer market size.

Challenges2 items

The Red Blood Cell Lysis Buffer market faces challenges related to supply chain disruptions and raw material availability, which can impact the production and distribution of Red Blood Cell Lysis Buffer products, affecting the Red Blood Cell Lysis Buffer market size.

Ensuring the quality and consistency of Red Blood Cell Lysis Buffer products is a significant challenge, particularly in light of increasing regulatory requirements and competitive pressures in the Red Blood Cell Lysis Buffer market.

Market Segmentation

Loading chart…

The Application segment of the Red Blood Cell Lysis Buffer market refers to the various uses of these buffers in research and diagnostic applications. This segment contributes significantly to the overall market size, with applications in molecular biology, biochemistry, and clinical diagnostics. The Red Blood Cell Lysis Buffer segmentation is critical in understanding the market dynamics, as it helps identify the most prominent applications driving the market growth.

The Types segment of the Red Blood Cell Lysis Buffer market encompasses various subtypes, including [object Object] and [object Object]. This segmentation is essential in understanding the market taxonomy, as it highlights the different product offerings catering to specific research and diagnostic needs. The types of Red Blood Cell Lysis Buffers available in the market play a crucial role in determining the overall market size, with each subtype contributing to the growth of the market.

Red Blood Cell Lysis Buffer Segmentation Breakdown7 items

Application

Research Laboratory

Hospital

Others

Types

Red Blood Cell Lysis Buffer, Type A (Nucleic Acid Purification)

Red Blood Cell Lysis Buffer, Type B (Flow Cytometric Analysis)

Regional Insights

Loading chart…

The Red Blood Cell Lysis Buffer market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 35% of the global market, and also the fastest-growing region, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure. In North America, key drivers include a mature ecosystem, high demographics awareness, and established infrastructure, contributing to a market share of around 30%. Europe follows with a share of around 20%, driven by regional forecast indicating growing demand for Red Blood Cell Lysis Buffer solutions.

In Latin America, the market is driven by growing investments in healthcare, increasing adoption of diagnostic technologies, and a rising ecosystem maturity, resulting in a market share of around 10%. The Middle East & Africa region has a market share of around 5%, driven by limited but growing infrastructure, increasing demographics awareness, and favorable policies. These regional insights are crucial for understanding the Red Blood Cell Lysis Buffer market growth and for making informed strategic decisions.

Competitive Landscape

The Red Blood Cell Lysis Buffer market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The Red Blood Cell Lysis Buffer competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies emphasize distribution and pricing strategies.

Companies in the Red Blood Cell Lysis Buffer market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies must develop unique value propositions, such as technology, service model, channel strength, customization, or cost advantages. The following companies illustrate different strategic focuses:

Norgen Biotek Corp. regional expansion

PeproTech, Inc. premium pricing

Absin innovation pipeline

Beijing Solarbio Science and Technology Co., Ltd. local manufacturing

Beyotime Biotechnology OEM tie-ups

Sigma-Aldrich vertical integration

Key Red Blood Cell Lysis Buffer Companies7 items

Norgen Biotek Corp.

PeproTech, Inc.

Absin

Beijing Solarbio Science and Technology Co., Ltd.

Beyotime Biotechnology

Sigma-Aldrich

Invent Biotechnologies, Inc.

Market Ecosystem

The Red Blood Cell Lysis Buffer ecosystem encompasses a complex network of participants, spanning from upstream technology providers and suppliers to downstream end users. This ecosystem can be segmented into three primary tiers: upstream, midstream, and downstream, with value being created and captured through the interactions and relationships between these tiers. The Red Blood Cell Lysis Buffer ecosystem is characterized by the flow of value from technology providers and suppliers, through integrators and channels, to end users, with each participant playing a distinct role in the creation and capture of value.

Raw material/component suppliers — provide key ingredients

OEMs / manufacturers — produce Red Blood Cell Lysis Buffer products

Technology providers — develop underlying technologies

Distributors / channel partners — facilitate product distribution

Service providers / after-sales — offer support and maintenance services

End users / buyers — utilize Red Blood Cell Lysis Buffer products

Regulators/standards bodies — establish guidelines and standards

In the Red Blood Cell Lysis Buffer ecosystem, control points are primarily held by regulators and standards bodies, as well as by large OEMs and technology providers, who influence adoption through their products and services. Dependency risks arise from input constraints, such as the availability of raw materials, and from standards and approvals, which can impact the ability of participants to operate effectively. Switching costs and partnerships can also pose challenges, particularly for end users who may be invested in specific products or technologies. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and market conditions, highlighting the need for a nuanced understanding of the Red Blood Cell Lysis Buffer ecosystem through a detailed value chain analysis.

Recent Industry Insights

The Red Blood Cell Lysis Buffer industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed between key players to enhance research and development capabilities. Furthermore, there have been strategic mergers and acquisitions to expand product portfolios and strengthen market presence. Recent product launches have focused on improving the efficiency and specificity of red blood cell lysis, catering to the growing demand for high-quality lysates in research and diagnostic applications.

Additionally, regulatory changes have emphasized the need for standardized protocols and stringent quality control measures in the production of red blood cell lysis buffers. This shift has prompted companies to invest in technological advancements and process optimizations, ensuring compliance with evolving regulatory requirements. The Red Blood Cell Lysis Buffer market is poised for continued growth, driven by increasing research activities, advancements in cell biology, and expanding applications in biotechnology and pharmaceutical industries.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Red Blood Cell Lysis Buffer market. The market attractiveness of this sector is driven by increasing demand for high-quality research reagents. The Red Blood Cell Lysis Buffer market outlook is expected to remain positive, with a long-term outlook that indicates steady growth. However, competitive intensity is high, with several key players competing for market share.

The innovation landscape is characterized by ongoing research and development, with a focus on improving product quality and efficiency. The demand-supply balance is expected to remain stable, with manufacturers working to meet the needs of researchers and scientists. Key risk factors include fluctuations in raw material prices and regulatory changes, which could impact the market. Overall, the Red Blood Cell Lysis Buffer market is poised for continued growth, driven by increasing demand and ongoing innovation.

12 items

1. Executive Summary

2. Red Blood Cell Lysis Buffer Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Red Blood Cell Lysis Buffer Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Red Blood Cell Lysis Buffer Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Red Blood Cell Lysis Buffer Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Red Blood Cell Lysis Buffer Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Red Blood Cell Lysis Buffer Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Red Blood Cell Lysis Buffer Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Red Blood Cell Lysis Buffer Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Red Blood Cell Lysis Buffer Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Red Blood Cell Lysis Buffer Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Red Blood Cell Lysis Buffer Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Red Blood Cell Lysis Buffer Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Red Blood Cell Lysis Buffer Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Red Blood Cell Lysis Buffer Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Red Blood Cell Lysis Buffer Market Competition by Key Manufacturers

9.1. Global Red Blood Cell Lysis Buffer Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Red Blood Cell Lysis Buffer: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Norgen Biotek Corp.

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. PeproTech, Inc.

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Absin

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Beijing Solarbio Science and Technology Co., Ltd.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Beyotime Biotechnology

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Sigma-Aldrich

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Invent Biotechnologies, Inc.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Red Blood Cell Lysis Buffer Market

Figure 4: Global Red Blood Cell Lysis Buffer Market: Drivers

Figure 5: Global Red Blood Cell Lysis Buffer Market: Challenges

Figure 6: Global Red Blood Cell Lysis Buffer Market: Trends

Figure 7: Global Red Blood Cell Lysis Buffer Market: Opportunity

Figure 8: Global Red Blood Cell Lysis Buffer Market: Restraint

Figure 9: Global Red Blood Cell Lysis Buffer Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Red Blood Cell Lysis Buffer Market Value (USD Million) By Region

Figure 19: Global Red Blood Cell Lysis Buffer Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Red Blood Cell Lysis Buffer Market Value (USD Million) By Region

Figure 27: Global Red Blood Cell Lysis Buffer Market Share (%) By: Regions (2032)

Figure 28: Global Red Blood Cell Lysis Buffer Market Volume (K) By Region

Figure 29: Global Red Blood Cell Lysis Buffer Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Red Blood Cell Lysis Buffer Market Value (USD Million) By Region

Figure 37: Global Red Blood Cell Lysis Buffer Market Share (%) By: Regions (2032)

Figure 38: Global Red Blood Cell Lysis Buffer Market Volume (K) By Region

Figure 39: Global Red Blood Cell Lysis Buffer Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Red Blood Cell Lysis Buffer Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Red Blood Cell Lysis Buffer Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Red Blood Cell Lysis Buffer Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Red Blood Cell Lysis Buffer Market Value (USD Million) By Region

Table 14: Global Red Blood Cell Lysis Buffer Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Red Blood Cell Lysis Buffer Market Volume (K) By Region

Table 31: Global Red Blood Cell Lysis Buffer Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Red Blood Cell Lysis Buffer Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Red Blood Cell Lysis Buffer Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Red Blood Cell Lysis Buffer Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Norgen Biotek Corp. Basic Information And Sales Area

Table 52: Norgen Biotek Corp.. Products Portfolio

Table 53: PeproTech, Inc. Basic Information And Sales Area

Table 54: PeproTech, Inc.. Products Portfolio

Table 55: Absin Basic Information And Sales Area

Table 56: Absin. Products Portfolio

Table 57: Beijing Solarbio Science and Technology Co., Ltd. Basic Information And Sales Area

Table 58: Beijing Solarbio Science and Technology Co., Ltd.. Products Portfolio

Table 59: Beyotime Biotechnology Basic Information And Sales Area

Table 60: Beyotime Biotechnology. Products Portfolio

Table 61: Sigma-Aldrich Basic Information And Sales Area

Table 62: Sigma-Aldrich. Products Portfolio

Table 63: Invent Biotechnologies, Inc. Basic Information And Sales Area

Table 64: Invent Biotechnologies, Inc.. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Red Blood Cell Lysis Buffer Market Value (USD Million) By Region

Table 74: Global Red Blood Cell Lysis Buffer Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Red Blood Cell Lysis Buffer Market Volume (K) By Region

Table 91: Global Red Blood Cell Lysis Buffer Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Red Blood Cell Lysis Buffer Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Norgen Biotek Corp.; PeproTech, Inc.; Absin; Beijing Solarbio Science and Technology Co., Ltd.; Beyotime Biotechnology; Sigma-Aldrich; Invent Biotechnologies, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing investments in biotechnology and pharmaceutical research are expected to fuel the demand for Red Blood Cell Lysis Buffer, further expanding the Red Blood Cell Lysis Buffer market.

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Red Blood Cell Lysis Buffer Segmentation Breakdown7 items

Application

Research Laboratory

Hospital

Others

Types

Red Blood Cell Lysis Buffer, Type A (Nucleic Acid Purification)

Red Blood Cell Lysis Buffer, Type B (Flow Cytometric Analysis)

Regional Insights

Loading chart…

Competitive Landscape

Norgen Biotek Corp. regional expansion

PeproTech, Inc. premium pricing

Absin innovation pipeline

Beijing Solarbio Science and Technology Co., Ltd. local manufacturing

Beyotime Biotechnology OEM tie-ups

Sigma-Aldrich vertical integration

Key Red Blood Cell Lysis Buffer Companies7 items

Norgen Biotek Corp.

PeproTech, Inc.

Absin

Beijing Solarbio Science and Technology Co., Ltd.

Beyotime Biotechnology

Sigma-Aldrich

Invent Biotechnologies, Inc.

Market Ecosystem

Raw material/component suppliers — provide key ingredients

OEMs / manufacturers — produce Red Blood Cell Lysis Buffer products

Technology providers — develop underlying technologies

Distributors / channel partners — facilitate product distribution

Service providers / after-sales — offer support and maintenance services

End users / buyers — utilize Red Blood Cell Lysis Buffer products

Regulators/standards bodies — establish guidelines and standards

Recent Industry Insights

Analyst Overview

Table of Contents